Dong‐Ying Xie

1.4k total citations
48 papers, 962 citations indexed

About

Dong‐Ying Xie is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Dong‐Ying Xie has authored 48 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 31 papers in Hepatology and 11 papers in Immunology. Recurrent topics in Dong‐Ying Xie's work include Hepatitis B Virus Studies (32 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (18 papers). Dong‐Ying Xie is often cited by papers focused on Hepatitis B Virus Studies (32 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (18 papers). Dong‐Ying Xie collaborates with scholars based in China and United States. Dong‐Ying Xie's co-authors include Zhiliang Gao, Liang Peng, Bingliang Lin, Chan Xie, Yubao Zheng, Jing Liu, Haipeng Zhu, Shi-Bin Xie, Zhiliang Gao and Yinong Ye and has published in prestigious journals such as PLoS ONE, Hepatology and Frontiers in Immunology.

In The Last Decade

Dong‐Ying Xie

45 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Ying Xie China 13 563 395 374 320 195 48 962
Babak Noorinayer Iran 10 332 0.6× 261 0.7× 244 0.7× 230 0.7× 175 0.9× 14 679
Shi-Bin Xie China 12 328 0.6× 283 0.7× 173 0.5× 143 0.4× 126 0.6× 21 558
Borut Klopcic Australia 10 264 0.5× 264 0.7× 160 0.4× 58 0.2× 233 1.2× 13 747
Heather A. Crosby United Kingdom 13 646 1.1× 180 0.5× 617 1.6× 75 0.2× 251 1.3× 16 1.0k
Weizhen Weng China 10 157 0.3× 108 0.3× 127 0.3× 110 0.3× 107 0.5× 20 412
Dirk Nierhoff Germany 14 395 0.7× 181 0.5× 443 1.2× 58 0.2× 446 2.3× 41 881
Andrew J. Robson United Kingdom 7 317 0.6× 202 0.5× 345 0.9× 44 0.1× 211 1.1× 8 799
Jinsub Choi South Korea 14 218 0.4× 140 0.4× 330 0.9× 44 0.1× 317 1.6× 21 872
Fabien Lavocat France 18 361 0.6× 399 1.0× 28 0.1× 56 0.2× 152 0.8× 26 833
Filoména Conti France 17 481 0.9× 331 0.8× 272 0.7× 9 0.0× 153 0.8× 35 868

Countries citing papers authored by Dong‐Ying Xie

Since Specialization
Citations

This map shows the geographic impact of Dong‐Ying Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Ying Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Ying Xie more than expected).

Fields of papers citing papers by Dong‐Ying Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Ying Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Ying Xie. The network helps show where Dong‐Ying Xie may publish in the future.

Co-authorship network of co-authors of Dong‐Ying Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Ying Xie. A scholar is included among the top collaborators of Dong‐Ying Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Ying Xie. Dong‐Ying Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hong, Wenxin, Jianfeng He, Jian Wang, et al.. (2024). Severe Organ Impairment Was Common in Elderly Individuals with Dengue in Guangdong, China. American Journal of Tropical Medicine and Hygiene. 111(3). 610–616. 1 indexed citations
3.
4.
Li, Xing, et al.. (2023). LAG3+ erythroid progenitor cells inhibit HBsAg seroclearance during finite pegylated interferon treatment through LAG3 and TGF-β. Antiviral Research. 213. 105592–105592. 1 indexed citations
5.
Lei, Ziying, et al.. (2021). Hepatotoxicity of iodine-131 ablation for post-surgical differentiated thyroid cancer patients with hepatitis B virus infection. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101631–101631. 1 indexed citations
6.
7.
Wu, Lili, Xiaoyan Li, Hong Deng, et al.. (2021). Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon. Virus Research. 309. 198657–198657. 3 indexed citations
8.
Chen, Dabiao, et al.. (2021). The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α. Annals of Translational Medicine. 9(5). 414–414. 7 indexed citations
9.
Xu, Wenxiong, Qian Zhang, Xiang Zhu, et al.. (2018). 48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–11. 8 indexed citations
10.
Zhao, Qiyi, et al.. (2018). Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–9. 7 indexed citations
11.
Li, Xinhua, Jing Huang, Hong Deng, et al.. (2018). IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation. BMC Gastroenterology. 18(1). 61–61. 15 indexed citations
12.
Deng, Hong, et al.. (2016). Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients. Hepatitis Monthly. 16(9). e40263–e40263. 20 indexed citations
13.
Lei, Ziying, Jianyun Zhu, Ke Wang, et al.. (2015). Soluble ST2 Plasma Concentrations Predict Mortality in HBV‐Related Acute‐on‐Chronic Liver Failure. Mediators of Inflammation. 2015(1). 535938–535938. 19 indexed citations
14.
Guo, Xiaoyan, et al.. (2012). Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C.. PubMed. 125(13). 2334–8. 7 indexed citations
15.
Zhang, Xiaohong, et al.. (2012). [Genetic variation of IL-28B is associated with treatment response of patients with chronic hepatitis C].. PubMed. 26(4). 298–300. 1 indexed citations
16.
Zheng, Yubao, Dong‐Ying Xie, Liang Peng, et al.. (2012). A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study. Hepatology International. 6(4). 727–734. 4 indexed citations
17.
Peng, Liang, Dong‐Ying Xie, Bingliang Lin, et al.. (2011). Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes. Hepatology. 54(3). 820–828. 283 indexed citations
18.
Zhang, Xiaohong, et al.. (2010). Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B. Hepatology International. 4(3). 615–620. 44 indexed citations
19.
Xie, Dong‐Ying, et al.. (2008). [The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].. PubMed. 16(5). 341–4. 4 indexed citations
20.
Xie, Dong‐Ying, et al.. (1999). [Differential diagnosis in patients with tuberculous meningitis and cryptococcal meningitis].. PubMed. 22(12). 731–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Babak Noorinayer Breakdown of academic impact, for papers by Shi-Bin Xie Breakdown of academic impact, for papers by Borut Klopcic Breakdown of academic impact, for papers by Heather A. Crosby Breakdown of academic impact, for papers by Weizhen Weng Breakdown of academic impact, for papers by Dirk Nierhoff Breakdown of academic impact, for papers by Andrew J. Robson Breakdown of academic impact, for papers by Jinsub Choi Breakdown of academic impact, for papers by Fabien Lavocat Breakdown of academic impact, for papers by Filoména Conti
Rankless by CCL
2026